Answers are grounded in this paper and cite their sources.
Selective inhibitors of voltage-activated K(+) channels are needed for the treatment of multiple sclerosis. In this work it was discovered that porphyrins bearing 2-4 carbon alkyl ammonium side chains predominantly blocked the Kv1.1 current whilst Kv1.2 was susceptible to a porphyrin bearing polyamine side chains.
No takes yet. Share an insight, caveat, or question.
Daly et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: